1Silverstein A. Intracranial bleeding in hemophilia. Arch Neurol,1960, 3: 141-157.
2Nuss R, Soucie JM, Evatt B. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol, 2001,68:37-42.
3Arkin S, Cooper HA, Hurter JJ, et al. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program. Haemostasis, 1998, 28:93-98.
4Hough RE, Hampton KK, Preston FE, et al. Recombinant Vlla concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors. Br J Haematol, 2000, lll :974-979.
同被引文献9
1Hougie C, Sargeant R. Antigen-biological-activity ratio for fac- tor VIII[J]. Lancet, 1973,1 (7803) :616-617.
2Chalmers E, Williams M, Brennand J, et al. Guideline on the management of haemophilia in the fetus and neonate [ J ]. Br J Haematol, 2011, 154 ( 2 ) : 208-215. DOI: 10. 1111/j. 1365- 2141. 2010.08545. x.
3Hough RE, Hampton KK, Preston FE, et al. Recombinant VIIa concentrate in the management of bleeding following prothrom- bin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors [ J ]. Br J Haematol. 2000,111 ( 3 ) :974-979.
4Nuss R, Soucie JM, Evatt B, et al. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemor- rhage[J]. Am J Hematol,2001,68 ( 1 ) :37-42.
5Klinge J, Auberger K, Auerswald G, et al. Prevalence and out- come of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis(GTH) [J]. Eur J Pediatr, 1999,158 Suppl 3 : S162-165.
